ASTRO 2026, bladder cancer, Adaptive Radioresistance in Muscle-Invasive Bladder Cancer, Tumour-Microenvironment co-Evolution, Biomarker-Guided Radiotherapy.

Prof Petra Hamerlik is leading a study using tear fluid to test for brain tumours at the University of Manchester.

‘Combination strategies within radiobiology – past and future directions’

A UK-led clinical trial is set to test a new drug that could make cutting-edge cancer treatments safer and more accessible for thousands of patients with multiple myeloma, a type of blood cancer.

Tumour hypoxia is associated with treatment resistance and adverse outcome in cervical cancer, but clinically robust methods for hypoxia stratificatio…

A UK-led clinical trial is set to test a new drug that could make cutting-edge cancer treatments safer and more accessible for thousands of patients with multiple myeloma, a type of blood cancer.

Explore the range of postgraduate cancer research opportunities available in Manchester.

Tracy Tomlinson was offered the clinical trial for ovarian cancer at The Christie hospital in Manchester.

In June 2026, I travelled to Budapest, Hungary, to attend the European Association for Cancer Research Congress. As one of Europe’s leading cancer research meetings, EACR brings together thousands of scientists working across basic, preclinical and translational cancer research.

In this video Adesewa takes us through her typical day, including taking us on a tour of her lab facilities and carrying out experiments, as well as her advice to students thinking of doing a PhD in Manchester.

In June 2026, I travelled to Budapest, Hungary, to attend the European Association for Cancer Research Congress. As one of Europe’s leading cancer research meetings, EACR brings together thousands of scientists working across basic, preclinical and translational cancer research.

Manchester scientists have identified a new way to target lung cancer caused by the notorious KRAS mutation, expanding the shortlist of lung cancers treatable with targeted therapies.

Explore the range of postgraduate cancer research opportunities available in Manchester.

Roger Slater, 75, hopes a major research project could help other men avoid the effects he suffered.

Every year, thousands of cancer patients treated at The Christie NHS Foundation Trust, Manchester University NHS Foundation Trust and Northern Care Alliance NHS Foundation Trust choose to donate tissue samples to the Manchester Cancer Research Centre Biobank.